Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

Keywords

MedicinePlaceboThrombolysisModified Rankin ScaleInternal medicineClinical endpointStroke (engine)Fibrinolytic agentClinical trialTissue plasminogen activatorRandomized controlled trialAbsolute risk reductionAnesthesiaSurgeryMyocardial infarctionConfidence intervalIschemiaIschemic stroke

Affiliated Institutions

Related Publications

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Werner Hacke , Markku Kaste , Erich Bluhmki +11 more

As compared with placebo, intravenous alteplase administered between 3 and 4.5 hours after the onset of symptoms significantly improved clinical outcomes in patients with acute ...

2008 New England Journal of Medicine 6420 citations

Endovascular Thrombectomy for Anterior Circulation Stroke

Chester K. Yarbrough , Charlene Ong , Alexander Beyer +2 more

Background and Purpose— Stroke affects ≈700 000 patients annually. Recent randomized controlled trials comparing endovascular thrombectomy (ET) with medical therapy, including i...

2015 Stroke 65 citations

Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group

Thrombolytic therapy for acute ischemic stroke has been approached cautiously because there were high rates of intracerebral hemorrhage in early clinical trials. We performed a ...

1995 New England Journal of Medicine 11503 citations

A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaboration

Rachael MacIsaac , Pooja Khatri , Martin Bendszus +35 more

Rationale Endovascular treatment has been shown to restore blood flow effectively. Second-generation medical devices such as stent retrievers are now showing overwhelming effica...

2015 International Journal of Stroke 14 citations

Efficacy of Intra-Arterial Fibrinolysis for Acute Ischemic Stroke

Meng Lee , Keun‐Sik Hong , Jeffrey L. Saver

Background and Purpose— Although intra-arterial (IA) fibrinolysis for acute ischemic stroke has been clinically available for many years, it is not a therapy approved by the US ...

2010 Stroke 154 citations

Publication Info

Year: 1998
Type: article
Volume: 352
Issue: 9136
Pages: 1245-1251
Citations: 3556
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

3556

OpenAlex

Cite This

APA Style

                            
                                
                                    Werner Hacke, 
                                
                                    Markku Kaste, 
                                
                                    Cesare Fieschi
                                
                                et al.
                            
                            (1998). 
                            Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). 
                            The Lancet
                            , 352
                            (9136)
                            , 1245-1251.
                            https://doi.org/10.1016/s0140-6736(98)08020-9
                        

Identifiers

DOI: 10.1016/s0140-6736(98)08020-9